Janus Henderson Group

Janus Henderson Group Portfolio holdings

AUM $204B
 

Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.

This Quarter Return
-5.91%
1 Year Return
+26.64%
3 Year Return
+125.28%
5 Year Return
+196.8%
10 Year Return
+578.78%
AUM
$207B
AUM Growth
+$207B
Cap. Flow
-$12.6B
Cap. Flow %
-6.1%
Top 10 Hldgs %
25.33%
Holding
2,774
New
230
Increased
1,123
Reduced
1,078
Closed
135

Sector Composition

1 Technology 31.62%
2 Healthcare 18.99%
3 Consumer Discretionary 10.82%
4 Financials 10.24%
5 Industrials 8.9%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
GERN icon
2601
Geron
GERN
$893M
$67K ﹤0.01%
49,046
+21
+0% +$29
BLUE
2602
DELISTED
bluebird bio
BLUE
$66K ﹤0.01%
13,648
+17
+0.1% +$82
MUX icon
2603
McEwen Inc.
MUX
$625M
$65K ﹤0.01%
76,809
MMAT
2604
DELISTED
Meta Materials Inc. Common Stock
MMAT
$65K ﹤0.01%
39,000
OCUL icon
2605
Ocular Therapeutix
OCUL
$2.12B
$64K ﹤0.01%
13,076
+3
+0% +$15
VERU icon
2606
Veru
VERU
$47.6M
$62K ﹤0.01%
12,744
+2
+0% +$10
DOMA
2607
DELISTED
Doma Holdings, Inc.
DOMA
$62K ﹤0.01%
28,665
-2,059,227
-99% -$4.45M
INSG icon
2608
Inseego
INSG
$185M
$61K ﹤0.01%
15,175
+14
+0.1% +$56
SKLZ icon
2609
Skillz
SKLZ
$135M
$61K ﹤0.01%
+20,098
New +$61K
ZOM
2610
DELISTED
Zomedica Corp.
ZOM
$60K ﹤0.01%
177,068
RBBN icon
2611
Ribbon Communications
RBBN
$722M
$59K ﹤0.01%
19,034
+4
+0% +$12
LTCH
2612
DELISTED
Latch, Inc. Common Stock
LTCH
$57K ﹤0.01%
13,227
+9
+0.1% +$39
VBIV
2613
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$55K ﹤0.01%
33,337
SDC
2614
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
$54K ﹤0.01%
20,835
+5
+0% +$13
LAB icon
2615
Standard BioTools
LAB
$481M
$52K ﹤0.01%
14,408
+1
+0% +$4
AGFY icon
2616
Agrify
AGFY
$92M
$50K ﹤0.01%
10,746
-164
-2% -$763
VLDR
2617
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$49K ﹤0.01%
19,151
+3
+0% +$8
AMWL icon
2618
American Well
AMWL
$111M
$48K ﹤0.01%
11,289
+111
+1% +$472
MRSN icon
2619
Mersana Therapeutics
MRSN
$36.5M
$45K ﹤0.01%
11,198
-9
-0.1% -$36
CLVS
2620
DELISTED
Clovis Oncology, Inc.
CLVS
$42K ﹤0.01%
20,347
+77
+0.4% +$159
VKTX icon
2621
Viking Therapeutics
VKTX
$3.04B
$40K ﹤0.01%
13,409
PGEN icon
2622
Precigen
PGEN
$1.34B
$39K ﹤0.01%
18,569
-3
-0% -$6
VRM icon
2623
Vroom, Inc. Common Stock
VRM
$148M
$37K ﹤0.01%
14,022
-7,252,155
-100% -$19.1M
CRIS icon
2624
Curis
CRIS
$20.9M
$33K ﹤0.01%
13,988
-180,370
-93% -$426K
EDU icon
2625
New Oriental
EDU
$7.85B
$31K ﹤0.01%
26,990